Recently, a research team found that SKP2 is overexpressed in 45.5% of papillary thyroid cancers and that SKP2 expression is also significantly associated with extrathyroidal extension and distant metastasis [35]. Here, SKP2 is linked to thyroid gland papillary carcinoma.